BV
Bavarian Nordic A/S
BVNRY · OTC
$10.50 +0.12% (+$0.01)
1M +13.36%
Market Cap 15.6B kr
P/E Ratio 10.04x
Div. Yield -
ROE 12.00%
Bulios Fair Price
$14.01
33.5% upside
Trenutna cena
$10.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BVNRY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
96 /100
Cheap EV/EBITDA 5.68x
P/S 2.57x
P/B 1.18x
Growth
100 /100
Growing Book val. growth 21.64%
Rev. growth 23.49%
FCF growth N/A
Profitability
91 /100
Strong Net margin 25.64%
Op. margin 16.57%
FCF margin 20.21%
Quality
47 /100
Average ROE 12.00%
ROA 10.58%
Asset turnover 0.41x
Debt
100 /100
Low Current ratio 6.53x
Int. coverage 137.78x
Net debt/EBITDA -0.24x
Stability
32 /100
Unstable Rev. volatility 76.93%
EPS volatility 285.42%
Profitable years 3
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BVNRY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul John Chaplin
Employees
1,795
Headquarters
Hellerup